Syverson Strege & CO Bristol Myers Squibb CO Transaction History

Syverson Strege & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $1,314 - $1,490	20 Added 1.92%	1,062 $73,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $17 - $10,219	-133 Reduced 11.32%	1,042 $74,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $4,720 - $5,198	65 Added 5.86%	1,175 $90,000
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $4,180 - $5,012	68 Added 6.53%	1,110 $81,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $375 - $437	-7 Reduced 0.67%	1,042 $65,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $414 - $485	7 Added 0.67%	1,049 $62,000
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $13,248 - $14,427	-214 Reduced 17.04%	1,042 $70,000
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $7,951 - $8,943	134 Added 11.94%	1,256 $79,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $64,784 - $73,412	1,122 New	1,122 $70,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

Stay updated on Syverson Strege & CO with notifications on news.